学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
Rifamycin treatment of tuberculosis in a patient receiving atenolol: Less interaction with rifabutin than with rifampin
被引:7
作者
:
Goldberg, SV
论文数:
0
引用数:
0
h-index:
0
机构:
Publ Hlth Seattle & King Cty, TB Control Program, Seattle, WA 98104 USA
Goldberg, SV
Hanson, D
论文数:
0
引用数:
0
h-index:
0
机构:
Publ Hlth Seattle & King Cty, TB Control Program, Seattle, WA 98104 USA
Hanson, D
Peloquin, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Publ Hlth Seattle & King Cty, TB Control Program, Seattle, WA 98104 USA
Peloquin, CA
机构
:
[1]
Publ Hlth Seattle & King Cty, TB Control Program, Seattle, WA 98104 USA
[2]
Virginia Mason Med Ctr, Seattle, WA 98101 USA
[3]
Natl Jewish Med & Res Ctr, Pharmacokinet Lab, Denver, CO USA
来源
:
CLINICAL INFECTIOUS DISEASES
|
2003年
/ 37卷
/ 04期
关键词
:
D O I
:
10.1086/376648
中图分类号
:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号
:
100102 ;
摘要
:
引用
收藏
页码:607 / 608
页数:2
相关论文
共 3 条
[1]
[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
[2]
Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis
[J].
Burman, WJ
论文数:
0
引用数:
0
h-index:
0
机构:
Denver Publ Hlth, Denver Metro TB Clin, Denver, CO 80204 USA
Burman, WJ
;
Gallicano, K
论文数:
0
引用数:
0
h-index:
0
机构:
Denver Publ Hlth, Denver Metro TB Clin, Denver, CO 80204 USA
Gallicano, K
;
Peloquin, C
论文数:
0
引用数:
0
h-index:
0
机构:
Denver Publ Hlth, Denver Metro TB Clin, Denver, CO 80204 USA
Peloquin, C
.
CLINICAL INFECTIOUS DISEASES,
1999,
28
(03)
:419
-429
[3]
A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin
[J].
Tattevin, P
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Tattevin, P
;
Revest, M
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Revest, M
;
Dupont, M
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Dupont, M
;
Arvieux, CD
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Arvieux, CD
;
Michelet, C
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Michelet, C
.
CLINICAL INFECTIOUS DISEASES,
2003,
36
(01)
:127
-128
←
1
→
共 3 条
[1]
[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
[2]
Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis
[J].
Burman, WJ
论文数:
0
引用数:
0
h-index:
0
机构:
Denver Publ Hlth, Denver Metro TB Clin, Denver, CO 80204 USA
Burman, WJ
;
Gallicano, K
论文数:
0
引用数:
0
h-index:
0
机构:
Denver Publ Hlth, Denver Metro TB Clin, Denver, CO 80204 USA
Gallicano, K
;
Peloquin, C
论文数:
0
引用数:
0
h-index:
0
机构:
Denver Publ Hlth, Denver Metro TB Clin, Denver, CO 80204 USA
Peloquin, C
.
CLINICAL INFECTIOUS DISEASES,
1999,
28
(03)
:419
-429
[3]
A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin
[J].
Tattevin, P
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Tattevin, P
;
Revest, M
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Revest, M
;
Dupont, M
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Dupont, M
;
Arvieux, CD
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Arvieux, CD
;
Michelet, C
论文数:
0
引用数:
0
h-index:
0
机构:
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
CHU Pontchaillou, Clin Malad Infect, F-35033 Rennes, France
Michelet, C
.
CLINICAL INFECTIOUS DISEASES,
2003,
36
(01)
:127
-128
←
1
→